Trends in glioblastoma treatment, survival, and disparities in access to care in the United States from 2004 to 2019: a National Cancer Database analysis
{{output}}
Objective: Population-based studies of histologically confirmed glioblastoma without molecular classification have demonstrated the doubling of 3-year overall survival (OS) since 2005 despite minimal additions to the treatment ar... ...
